Search

everythinglearnresearchcommunity

for

Search:↓

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

A woman with CHILD syndrome showed skin abnormalities, and the report suggests CHILD nevus and NEVIL might be the same condition, highlighting the need for diagnosis for genetic advice.

A woman's nail separation was likely caused by poor blood flow, and a treatment for similar conditions might help.

Surgery on a baby with a skin disorder improved eyelid position and eye health.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Horizontal scalp biopsy sections effectively diagnose and predict MPAA, with follicular density and inflammation impacting hair regrowth.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Minoxidil and finasteride effectively treat hair loss.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Genetics and hormones cause hair loss; finasteride treats it safely.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.